Apollo Ingredients FY26 Profit Soars 626% to ₹0.71 Crore

Net profit ₹0.71 crore; Total income ₹5.03 crore.

Reader Takeaway: Strong profit growth and capital raise; concerns linger over audit trail and related party transactions.

What just happened

Apollo Ingredients Ltd reported a significant financial turnaround for the fiscal year ending March 31, 2026. The company's total income surged by 63.3% to ₹5.03 crore (₹503.20 lakh) from ₹3.08 crore (₹308.20 lakh) in the previous year. Net profit after tax witnessed an even more dramatic increase, jumping 626.7% to ₹0.71 crore (₹70.85 lakh) from ₹0.10 crore (₹9.75 lakh).

Why this matters

This robust financial performance is underpinned by the company's strategic pivot towards becoming an integrated healthcare and agro-products provider. The significant rise in income and profit suggests early success in its new business direction. The company also raised ₹5 crore through a rights issue in August 2025, strengthening its balance sheet.

The backstory

Apollo Ingredients is actively reshaping its business model. It plans to engage in manufacturing, import, and export of Ayurvedic, Homeopathic, and Allopathic medicines. Additionally, its Memorandum of Association is being amended to include the cultivation, processing, and marketing of agricultural products, food additives, and nutraceuticals.

What changes now

With new leadership appointed in May 2026, including a Managing Director and Executive Director for Marketing, the company is set to execute its expanded business plans. The ₹5 crore raised from the rights issue will support these initiatives, although ₹3 crore was used for lease payments to a related party, Apollo Ingredients India Private Limited, a decision ratified by shareholders.

Risks to watch

Despite the positive financial trajectory, several concerns need investor attention. The company settled a compliance fine of ₹2.06 lakh with the BSE, indicating potential regulatory headwinds. Furthermore, the auditor's remarks pointed to a non-maintenance of an audit trail and edit log for accounting software, highlighting deficiencies in internal controls. The company name update on the BSE portal is also pending. Investors should also monitor transactions with related party Apollo Ingredients India Pvt Ltd to ensure they are at arm's length.

Peer comparison

(Information not available in the filing for direct peer comparison.)

Context metrics (time-bound)

As of March 31, 2026, Apollo Ingredients reported a current ratio of 18.53, indicating strong short-term liquidity. The company operates with a lean workforce, having only two permanent employees.

What to track next

Investors should closely monitor the company's progress in integrating its new healthcare and agro-product businesses. Compliance with audit trail requirements and transparency in related-party transactions will be crucial for sustained growth and investor confidence. The upcoming AGM will be important for further details on the company's long-term strategy.